Lycia leaps onto Nasdaq with $318M IPO as Windward eyes debut
Lycia leaps onto Nasdaq with $318M IPO as Windward eyes debut
Lycia Therapeutics
Private
Lycia Therapeutics is a biopharma company.
Company Info
Sector:Biotechnology
Headquarters:TBD
Founded:2000
Website:lyciatx.com/
Funding Round:TBD
Total Funding:TBD
Funding & Investor Relations
IPO Outlook / Plans
TBD
Recent News
Lycia raises $75M for food allergy and Graves’ disease
Lycia raises $75M for food allergy and Graves’ disease